| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Derek McAllan, Robin James Scott Cridland |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 2.70p |
| Change Today | 0.050p |
| % Change | 1.89 % |
| 52 Week High | 4.25 |
| 52 Week Low | 2.10 |
| Volume | 247,147 |
| Shares Issued | 533.35m |
| Market Cap | £14.40m |
| Beta | 0.83 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:28 | 85,220 @ 2.72p |
| 14:06 | 100,000 @ 2.78p |
| 10:35 | 20,727 @ 2.78p |
| 10:05 | 23,000 @ 2.61p |
| 08:08 | 18,200 @ 2.70p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research